Tadalafil shows promise for relief of lower urinary tract symptoms associate...( New York August 19 2008 Men with si...),Health
Navigation Links
Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH
Date:8/18/2008
New York, August 19, 2008 Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in the October 2008 issue of The Journal of Urology. Researchers from the University of Texas Southwestern Medical Center at Dallas, Northwestern University and Lilly Research Laboratories report on a randomized, double-blind, placebo-controlled study of over 1000 men in ten countries.
Claus G. Roehrborn, MD, Professor of Urology, University of Texas Southwestern Medical Center, states, "Since reports of erectile dysfunction (ED) incidence, pathophysiology and treatment have shown a possible link between BPH LUTS and ED. PDE5 inhibitors like tadalafil (Cialis) have received increased attention for treating BPH LUTS, although they are currently only approved for ED. The half-life of tadalafil is 17.5 hours, making it suitable as once daily therapy. Although the precise mechanism of action by which PDE5 inhibitors may alleviate LUTS is not completely understood, several putative mechanisms are currently under investigation."
Men with signs of BPH may experience LUTS, such as urinary frequency, urgency, intermittence, nocturia, straining, incomplete emptying or a weak urinary stream. LUTS increase with age with an overall prevalence of greater than 50% in men 50 years or older. Drugs currently used to treat these symptoms can produce unwanted side effects, including dizziness, low blood pressure and sexual dysfunction.
Participants in the tadalafil study were required to have at least a 6-month history of LUTS secondary to BPH. Subjects with a high PSA (more than 10 ng/ml) were excluded, as were subjects with other complicating conditions or conflicting drug treatments. Anyone who had undergone treatment for erectile dysfunction or other BPH treatments underwent a 4-week treatment
'/>"/>
| Contact: Linda Gruner l.gruner@elsevier.com 212-633-3923 Elsevier Health Sciences Source:Eurekalert |
Related medicine news :
1. FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. New research shows how chronic stress worsens neurodegenerative disease course
4. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
5. Circulating fats kill transplanted pancreas cells, study shows
6. New Heart Pump Shows Promise in Trial
7. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
8. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
11. Avocados may help prevent oral cancer, OSU study shows
Post Your Comments:
(Date:12/4/2009)...4, 2009 New findings by UT Southwestern researche...mmune disorders might also help slow the destructi... diagnosed with insulin-dependent (type 1) diabete...nile diabetes, cells in the pancreas called beta c...utoimmune process. , Researchers at UT Southwest...
(Date:12/4/2009)... Tender Corp., a leading manufacturer of o...ts designed to enhance consumers’ quality of...e coveted American Podiatric Medical Association (...g cream, HealthiFeet®. , ...eading manufacturer of over-the-counter topical cr...
(Date:12/4/2009)... MINNEAPOLIS, Dec. 4 New data from...ericans struggled to get enough to eat at some poi...ans one in six Americans struggled with hunger. To...lls CEO Ken Powell, NBC,s The Biggest Loser,s Bob ... B. Escarra are teaming up to turn on the producti...
(Date:12/4/2009)...HOMA CITY, Dec. 4 PD-Rx ...nounced revenue of $5,012,334 for the first quarte...e same period last year. Operating income and net... respectively, each a 70% decrease over the same p...decrease in pharmacy sector sales. This trend is ...
(Date:12/4/2009)...r 4, 2009 -- Substantial progress has been made ov... ability to diagnose and treat epilepsy and its co...ment has not reached most of the 50 million people...ree million people in the United States who have t... M.D., president of the American Epilepsy Society ...
Breaking Medicine News(10 mins):Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 2Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 3Health News:General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger' 4Health News:PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 2Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 3Health News:Epilepsy patients caught in treatment gap are not getting state-of-the-art care 4[0] FDA-approved drug may slow beta cell destruction in type 1 diabetes patients[0] Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval[0] General Mills, NBC's The Biggest Loser and Feeding America Join Forces to Rally America to 'Wake Up to Hunger'[0] PD-Rx Pharmaceuticals, Inc. Reports 1st Quarter Earnings[0] Epilepsy patients caught in treatment gap are not getting state-of-the-art care
...more often than biologists once thought. Cutting a...les into new structures is carried out by// the hu...e enhanced by this mechanism. This method could al...pe of protein required, an RNA template, produced ...
...nt on September 8 that treatment for a broad range...ten years. Researchers have found// treatments by ...gic reaction. These treatments harmlessly desensit...of Amsterdam, who is leading work on the developme...
... the hardness or elasticity of the liver has been ...c resonance imaging (MRI).// Initial tests show pr...for detecting liver fibrosis, a common condition t...volve complications and may be inaccurate due to s...
...eterious effect on young, developing brains, accor...at obesity in toddlers is linked to lower IQ score...with metabolic problems like diabetes, high choles...postulating that early-onset morbid obesity and th...
...m Children's Hospital Boston and the University of...ho must stay awake// all night may be able to put ...xide levels building up in the brain. Previous res... issue of the Journal of Neurochemistry and the Se...
...ing to get regular mammograms doe because of inacc...s.//
Breast Cancer Aotearoa Coalition Deputy...rcent of the eligible women have taken the offer f...t for early detection of breast abnormalities incl...
Other Medicine News:Health News:'Mix and match' of proteins may have a significant role in immunity 2Health News:Cure for food allergies is less than a decade away 2Health News:MRI Development Yields Breakthrough in Diagnosis of Liver Fibrosis 2Health News:Obesity Takes its Toll on IQ of Toddlers 2Health News:Nitric Oxide Levels In Brain Indicate Sleep 2'Mix and match' of proteins may have a significant role in immunityCure for food allergies is less than a decade awayMRI Development Yields Breakthrough in Diagnosis of Liver FibrosisObesity Takes its Toll on IQ of ToddlersNitric Oxide Levels In Brain Indicate SleepWomen Do Not Have Access To Free Mammograms
(Date:12/3/2009)..., SUNNYVALE, Calif., Dec. 3 /PRNewswire-FirstCall...armaceutical company focused on developing and com...he treatment of immune mediated diseases and cance... conference call on, Tuesday, December 8, 2009 at ...0am Pacific Time) to discuss clinical data regardi...
(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEGO, Ca...SPC3649 Successfully Inhibits miR-122, a microRNA ...by Significantly Reducing Hepatitis C,Virus in the...ith the,Hepatitis C Virus , - SPC3649 Dem...tance and,No Serious Adverse Events in the Treated...
(Date:12/3/2009)..., NASHVILLE, Tenn., Dec. 3 /PRNewswire-FirstCal...CPIX ) announced today that data from a recent cli...tion, an intravenous treatment for pain and fever,... Health-System Pharmacists (ASHP) Midyear Clinical... The new data will be displayed in a poster presen...
Breaking Medicine Technology:Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3Improved Endo Capsule Software enhances diagnostic experience 10493 1Improved Endo Capsule Software enhances diagnostic experience 10493 2Cocoa in Chocolate May Be Good for the Heart 59974 1Cocoa in Chocolate May Be Good for the Heart 59974 2Cocoa in Chocolate May Be Good for the Heart 59974 3Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 1Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 2Canadian Cardiovascular Society recognizes trailblazing work by U of Alberta heart researcher 59970 3[0] Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7[0] New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C[0] New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting
...lizing,single-use bioprocessing for development an... today that it has completed a product fill under ... Trius Therapeutics Phase I,clinical trial., "We ...his GMP fill,project, an effort that we were able ...eadline," said Leigh N. Pierce, president of Pacif...
...ension,s Twenty-Third Annual...ercent (45%) of patients with stage 1, hypertensi...n medoxomil), and BENICAR HCT(R) (olmesartan med...ormotension (< 120/80 mm Hg) (placebo:1.4%)., ...tage 1 hypertension were, able to reach a goal blo...
Other Medicine Technology:PacificGMP Completes GMP Product Fill for Trius Therapeutics 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7Automatic Blood Pressure Monitor
FreeStyle Freedom Blood Glucose Monitoring System
REAL-Time Continuous Glucose Monitoring
Monitect Multiple Drug Screen Cassette Test
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |